Calcipotriene/betamethasone dipropionate foam: primary evidence supporting its use in patients with psoriasis vulgaris. A narrative review

Psoriasis vulgaris is a chronic, immune-mediated disorder, which has a substantial impact on all aspects of patients’ quality of life. In most patients, the disease is mild to moderate and is successfully treated with topical agents. The most common therapy involves a vitamin D3 analogue (calcipotri...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Advances in Dermatology and Allergology
Auteurs principaux: Joanna Narbutt, Rafał Czajkowski, Aleksandra Lesiak, Witold Owczarek, Adam Reich, Jacek Szepietowski
Format: Article
Publié: Termedia Publishing House 2021-11-01
Sujets:
Psoriasis vulgaris
calcipotriene
betamethasone dipropionate
foam
topical administration
Accès en ligne:https://www.termedia.pl/Calcipotriene-betamethasone-dipropionate-foam-r-nprimary-evidence-supporting-its-use-in-patients-r-nwith-psoriasis-vulgaris-A-narrative-review,7,45455,1,1.html
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://www.termedia.pl/Calcipotriene-betamethasone-dipropionate-foam-r-nprimary-evidence-supporting-its-use-in-patients-r-nwith-psoriasis-vulgaris-A-narrative-review,7,45455,1,1.html

Documents similaires